---
category: news
title: "Drug companies invest in R&D-wide artificial intelligence"
excerpt: "According to a feature article in C&EN, some companies are committing to R&D-wide AI for support along the entire continuum of drug discovery, from identifying targets to designing drugs to analyzing clinical trials."
publishedDateTime: 2022-02-23T13:02:00Z
originalUrl: "https://www.acs.org/content/acs/en/pressroom/presspacs/2022/acs-presspac-february-23-2022/drug-companies-invest-in-r-d-wide-artificial-intelligence.html"
webUrl: "https://www.acs.org/content/acs/en/pressroom/presspacs/2022/acs-presspac-february-23-2022/drug-companies-invest-in-r-d-wide-artificial-intelligence.html"
type: article
quality: 37
heat: 37
published: false

provider:
  name: C&EN
  domain: acs.org

topics:
  - AI

images:
  - url: "https://www.acs.org/content/acs/en/pressroom/presspacs/2022/acs-presspac-february-23-2022/drug-companies-invest-in-r-d-wide-artificial-intelligence/_jcr_content/image.scale.small.png/cen.png"
    width: 318
    height: 239
    isCached: true

secured: "AY2UwHMCwvxVoRZkweiSkfhahMA6mKjXE/Fvm0FbYJm4i3xr3f9v1rw9iaNwoAzpVkrcWr428iScMt8z7phGkmLMzqdNFNhMUnZ3CkQ8CG1sgeSLeEEdErS24TP4ZwfGhh+mR9tniG11exGuDjaf9EmYlolCIRXizguTR4NAgVQui/75Wf1dTBYYv70xQxWcFTpWf9Qr67J7D+ZZR/MwbyxZEsbSDNUS22GZL0xKUcCEpZQbvvmbBPLaTzW6Azdim7LtLY3VtVzyAze7q59LHQNa/Bz8+m0QiS03CB9rkcJfsanyuuOPX3wTxTdCquzAbmBUUoROqSMnR9LPHGyZG2bQ/JPyDH9kHbkwaUIxusE=;Z9dWx4U0mdpLL501FeTfXg=="
---

